AI assistant
Sending…
VERU INC. — Director's Dealing 2009
Sep 15, 2009
34598_dirs_2009-09-15_e67d46db-c14d-4464-9776-1a494ae6d436.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FEMALE HEALTH CO (FHCO)
CIK: 0000863894
Period of Report: 2009-09-11
Reporting Person: POPE MICHAEL (VP and General Manager)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-09-11 | Common Stock, par value $.01 per share | M | 72800 | $1.4 | Acquired | 73050 | Direct |
| 2009-09-14 | Common Stock, par value $.01 per share | S | 15000 | $5.8179 | Disposed | 58050 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-09-11 | Common Stock Option | $1.4 | M | 72800 | Acquired | 2013-04-22 | Common Stock (72800) | Direct |
Footnotes
F1: Upon request by the Commission staff, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F2: The price reported above is the average transaction price. The range of prices for such transactions is $5.750 to $5.880.
F3: All option are fully vested. Options for one thirty-sixth of the shares vested on the 22nd of each month for the 36-month period commencing on April 22, 2003 and ending on April 22, 2006.
More from VERU INC.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 13
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 11